AGAMENNONE, Mariangela
 Distribuzione geografica
Continente #
NA - Nord America 3.276
EU - Europa 2.290
AS - Asia 2.286
SA - Sud America 316
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 8.211
Nazione #
US - Stati Uniti d'America 3.184
SG - Singapore 912
CN - Cina 642
IT - Italia 473
IE - Irlanda 327
UA - Ucraina 266
BR - Brasile 262
SE - Svezia 252
RU - Federazione Russa 243
GB - Regno Unito 218
VN - Vietnam 218
TR - Turchia 212
DE - Germania 183
IN - India 171
FR - Francia 118
FI - Finlandia 71
CA - Canada 58
GR - Grecia 40
HK - Hong Kong 29
BD - Bangladesh 23
PL - Polonia 19
AR - Argentina 18
MX - Messico 18
JP - Giappone 14
NL - Olanda 13
PT - Portogallo 13
ES - Italia 12
IQ - Iraq 12
EC - Ecuador 11
AT - Austria 10
ZA - Sudafrica 10
ID - Indonesia 9
VE - Venezuela 8
BE - Belgio 7
KR - Corea 7
CZ - Repubblica Ceca 6
EG - Egitto 5
EU - Europa 5
LT - Lituania 5
PK - Pakistan 5
RO - Romania 5
UZ - Uzbekistan 5
CH - Svizzera 4
CI - Costa d'Avorio 4
CL - Cile 4
PY - Paraguay 4
AU - Australia 3
DZ - Algeria 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
MA - Marocco 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
CO - Colombia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MY - Malesia 2
PR - Porto Rico 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MG - Madagascar 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
TG - Togo 1
TN - Tunisia 1
TO - Tonga 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.211
Città #
Singapore 646
San Jose 433
Chandler 334
Jacksonville 333
Dublin 324
Ashburn 249
Dallas 160
Southend 144
Princeton 141
Beijing 140
Nanjing 116
Izmir 107
Chieti 104
Los Angeles 86
Santa Clara 80
Cambridge 72
Ho Chi Minh City 67
Ann Arbor 65
Dearborn 65
Munich 61
Nanchang 55
New York 54
The Dalles 53
Wilmington 48
Tongling 41
Altamura 39
Woodbridge 38
Rome 35
Hanoi 30
Hong Kong 29
Buffalo 28
Redondo Beach 26
Dong Ket 25
São Paulo 25
Shenyang 23
Orem 21
Ottawa 21
Hebei 19
Kunming 19
Moscow 19
San Mateo 19
Tianjin 19
Stockholm 17
Washington 17
Da Nang 16
Jiaxing 16
Milan 16
Nuremberg 16
Atlanta 15
Denver 15
Grevenbroich 15
London 15
Montreal 15
St Louis 15
Boardman 14
Toronto 14
Changsha 13
Haiphong 13
Pune 13
Warsaw 13
Hefei 12
Tokyo 12
Brooklyn 11
Ferrara 11
Manchester 11
Norwalk 11
Poplar 11
Porto 11
Andover 10
Rio de Janeiro 10
Turku 10
Augusta 9
Chicago 9
Jinan 9
Napoli 9
Pescara 9
Bari 8
Houston 8
Mexico City 8
San Francisco 8
Siena 8
Teramo 8
Ankara 7
Belo Horizonte 7
Brussels 7
Council Bluffs 7
Curitiba 7
Hangzhou 7
Johannesburg 7
Leawood 7
Mumbai 7
Naples 7
Ningbo 7
Seattle 7
Shanghai 7
Torino 7
Biên Hòa 6
Boston 6
Brasília 6
Brno 6
Totale 5.016
Nome #
Peptidi della Lattoferrina per uso come inibitori ad ampio spettro dell'infezione da virus dell'influenza 277
Dual targeting of cancer-related human matrix metalloproteinases and carbonic anhydrases by chiral N-(biarylsulfonyl)-phosphonic acids 166
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2 159
AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids 159
Inibitori fosfonati di MMP: Influenza di variazioni strutturali in P3 sulla potenza e sulla selettività d’azione. 154
Derivatives of m-aminophenylboronic acid as ß-lactamases inhibitors. 147
Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection 145
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 145
alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. 144
Tripeptide Phosphonate Inhibitors of Matrix metalloproteinases. 143
Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus 139
Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulphonamide phosphonates 136
Sintesi enantioselettiva di inibitori fosfonati di metalloproteinasi di matrice. 134
Sintesi e valutazione biologica di Acidi Aril-Solfonil-Fosfonici come Inibitori selettivi delle Metalloproteinasi di Matrice (MMP). 133
Amber* force field implementation to dock alkyl and aryl boronic acids as ß-lactamases inhibitors. 133
Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach 132
New Matrix Metalloproteinase Inhibitors Based on N-hydroxyurea as zinc-binding group: synthesis, biological evaluation and computational studies. 126
Synthesis and biological evaluation of new matrix metalloproteinases inhibitors 126
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 126
Bisphosfonate matrix metalloproteinase inhibitors for the treatment of periodontitis: An in vitro study 125
Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity 125
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 124
Synthesis and biological evaluation of new Matrix Metalloproteinases Inhibitors. 124
An Integrated Computational Approach to Rationalize the Activity of Non-Zinc-Binding MMP-2 Inhibitors 122
VIRTUAL SCREENING APPROACHES FOR THE IDENTIFICATION OF NOVEL NON-ZINC-BINDING MMPs INHIBITORS 122
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 122
Amino Acid Derivatives as New Zinc Binding Groups for the Design of Selective Matrix Metalloproteinase Inhibitors 121
Synthesis and biological evaluation of sulfonyl phosphonic acids as new MMPs inhibitors. 120
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption 119
In vitro comparison of new bisphosphonic acids and zoledronate effects on human gingival fibroblasts viability, inflammation and matrix turnover 118
Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin 117
Synthesis, SAR and Biological Evaluation of alfa-Sulfonylphosphonic Acid as Selective Matrix Metalloproteinase Inhibitor 115
N-idrossiuree come inibitori di metalloproteinasi di matrice. 114
N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: Mode of binding in a complex with MMP-8 113
Ac‑tLeu‑Asp‑H is the minimal and highly effective human caspase‑3 inhibitor: biological and in silico studies 112
(2-Aminobenzothiazole)-Methyl-1,1-bisphosphonic acids: Targeting matrix metalloproteinase 13 inhibition to the bone 112
AMBER force field parameterization for alkyl and aryl boronic acids. 111
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 110
Identification of new anti-Candida compounds by ligand-based pharmacophore virtual screening 110
Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors 109
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy 108
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors 108
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 107
Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors 106
Probing the S1′ Site for the Identification of Non-Zinc-Binding MMP-2 Inhibitors 103
Mode of binding of R- and S- sulfonamide phosphonate inhibitors in the active site of MMP-8. 102
An Effective Virtual Screening Protocol to Identify Promising p53-MDM2 Inhibitors 101
Fragmenting the S100B–p53 Interaction: CombinedVirtual/Biophysical Screening Approaches to IdentifyLigands 101
Effects of Biphenyl Sulfonylamino Methyl Bisphosphonic Acids on Porphyromonas Gingivalis and Cytokine Secretion by Oral Epithelial Cells 100
synthesis and Activity of Endomorphin-1 and 2 analogues Incorporating Azetidine-(S)-2-carboxylic acid and Azetidine-3-carboxylic acid in place of native proline 99
Fragment-based discovery of S100B inhibitors: when structural information meets in silico prediction. 98
Antiviral Peptides as Anti-Influenza Agents 95
Multiple virtual screening approaches to identify novel, non-hydroxamic class-I HDAC inhibitors. 94
Non-zinc-binding inhibitors of MMP-13: GRID-based approaches to rationalize the binding process 92
Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors 91
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis 90
Identification of small molecules acting against H1N1 influenza A virus 87
Mimic catechins to develop selective MMP-2 inhibitors 87
Structure-based pharmacophore mapping of flexible macromolecules: targeting the S100B – p53 interaction. 84
Fragment-based discovery of S100B inhibitors combining computational and biophysical approaches. 84
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 82
Investigation of the N-BP Binding at FPPS by Combined Computational Approaches 82
Matrix metalloproteinases inhibitors, synthesis and biological evaluation. 81
Development of CDK4/6 Inhibitors: A Five Years Update 80
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 79
Hampering the early aggregation of PrP-E200K protein by charge-based inhibitors: a computational study 79
Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13 77
Discovery of a novel tetrapeptide against influenza a virus: Rational design, synthesis, bioactivity evaluation and computational studies 73
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors 67
Rational Design of Novel Peptidomimetics against Influenza A Virus: Biological and Computational Studies 65
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 63
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 63
Broad-Spectrum Activity of Small Molecules Acting against Influenza a Virus: Biological and Computational Studies 63
Het(aryl)isatin to het(aryl)aminoindoline scaffold hopping: A route to selective inhibitors of matrix metalloproteinases 61
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 59
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 58
Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity 53
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 52
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 46
Design and Evaluation of Synthesized Pyrrole Derivatives as Dual COX-1 and COX-2 Inhibitors Using FB-QSAR Approach 30
Targeting microbial β-CAs: bridging in silico screening with in vitro validation 22
Discovery and Evaluation of Novel Sulfonamide Derivatives Targeting Aromatase in ER+ Breast Cancer 8
Totale 8.569
Categoria #
all - tutte 33.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.226


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 43 39
2021/2022354 7 7 12 85 27 4 4 21 26 11 46 104
2022/20231.003 98 122 72 91 94 212 59 80 106 13 31 25
2023/2024530 32 20 36 6 28 202 112 7 6 36 6 39
2024/20251.199 56 239 164 10 15 47 25 110 111 68 145 209
2025/20262.750 218 126 331 392 240 155 475 195 327 230 61 0
Totale 8.569